208 related articles for article (PubMed ID: 35752862)
1. An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma.
Gao Y; Shen L; Dong T; Yang X; Cui H; Guo Y; Ma Y; Kong P; Cheng X; Zhang L; Cui Y
J Transl Med; 2022 Jun; 20(1):285. PubMed ID: 35752862
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycoproteomic profiling in esophageal squamous cell carcinoma.
Liu QW; Ruan HJ; Chao WX; Li MX; Jiao YL; Ward DG; Gao SG; Qi YJ
World J Gastroenterol; 2022 Aug; 28(29):3869-3885. PubMed ID: 36157541
[TBL] [Abstract][Full Text] [Related]
3. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
Zhang L; Gao Y; Zhang X; Guo M; Yang J; Cui H; Kong P; Niu X; Bi Y; Xu J; Yan T; Ma Y; Yang J; Qian Y; Wang F; Li H; Liu F; Cheng X; Cui Y
Theranostics; 2020; 10(24):11339-11358. PubMed ID: 33042286
[No Abstract] [Full Text] [Related]
4. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
5. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
6. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
7. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
[TBL] [Abstract][Full Text] [Related]
8. Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
Wang Y; Liao X; Ye Q; Huang L
Sci China Life Sci; 2018 Nov; 61(11):1389-1395. PubMed ID: 30076562
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma.
Pan H; Wu Z; Zhang H; Zhang J; Liu Y; Li Z; Feng W; Wang G; Liu Y; Zhao D; Zhang Z; Liu Y; Zhang Z; Liu X; Tao L; Luo Y; Wang X; Yang X; Zhang F; Li X; Guo X
Front Immunol; 2023; 14():981861. PubMed ID: 36999031
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
11. SLC7A9 as a Potential Biomarker for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma.
Baba H; Kanda M; Sawaki K; Nakamura S; Ueda S; Shimizu D; Koike M; Kodera Y; Fujii T
Ann Surg Oncol; 2022 Apr; 29(4):2699-2709. PubMed ID: 34773193
[TBL] [Abstract][Full Text] [Related]
12. Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation.
Shah P; Wang X; Yang W; Toghi Eshghi S; Sun S; Hoti N; Chen L; Yang S; Pasay J; Rubin A; Zhang H
Mol Cell Proteomics; 2015 Oct; 14(10):2753-63. PubMed ID: 26256267
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
14. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
15. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery.
Zhu T; Yang Q; Shao J; Chen Z; Cai B; Mao G
Virchows Arch; 2021 Nov; 479(5):905-917. PubMed ID: 34313839
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
19. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC.
Yang J; Kong P; Yang J; Jia Z; Hu X; Wang Z; Cui H; Bi Y; Qian Y; Li H; Wang F; Yang B; Yan T; Ma Y; Zhang L; Cheng C; Song B; Li Y; Xu E; Liu H; Gao W; Wang J; Liu Y; Zhai Y; Chang L; Wang Y; Zhang Y; Shi R; Liu J; Wang Q; Cheng X; Cui Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818781405. PubMed ID: 29950151
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]